v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Series A
IDoc Virtual Telehealth Solutions, Inc
Preferred Stock
Series A
DHAC
Preferred Stock
Series A
Preferred Stock
Dominion
Common Stock
VSee Note
Dominion
Common Stock
IDoc Virtual Telehealth Solutions, Inc
Dominion
Additional Paid- In Capital
VSee Note
Dominion
Additional Paid- In Capital
IDoc Virtual Telehealth Solutions, Inc
Dominion
VSee Note
Dominion
IDoc Virtual Telehealth Solutions, Inc
This American Doc
Common Stock
This American Doc
Additional Paid- In Capital
This American Doc
Non- Controlling Interest
IDoc Virtual Telehealth Solutions, Inc
Common Stock
IDoc Virtual Telehealth Solutions, Inc
Additional Paid- In Capital
IDoc Virtual Telehealth Solutions, Inc
DHAC
Additional Paid- In Capital
DHAC
Common Stock
VSee Note
Common Stock
Additional Bridge Notes
Common Stock
Exchange Note
Common Stock
ELOC Commitment Fee Note
Common Stock
Equity Line of Credit
Common Stock
Additional Paid- In Capital
VSee Note
Additional Paid- In Capital
Additional Bridge Notes
Additional Paid- In Capital
Exchange Note
Additional Paid- In Capital
ELOC Commitment Fee Note
Additional Paid- In Capital
Equity Line of Credit
Additional Paid- In Capital
Accumulated Deficit
Non- Controlling Interest
VSee Note
Additional Bridge Notes
Exchange Note
ELOC Commitment Fee Note
Equity Line of Credit
Total
Beginning balance (in Shares) at Dec. 31, 2023     0                                       4,639,643                            
Beginning balance at Dec. 31, 2023     $ 0                                       $ 464           $ 6,027,153 $ (10,001,858) $ (325,279)           $ (4,299,520)
Shares for iDoc acquisition (in Shares)                   354,441     4,950,000                                                
Shares for iDoc acquisition                   $ 36 $ (325,315) $ 325,279 $ 495 $ 67,450,680 $ 67,451,175                                            
Shares issued as conversion of iDoc debt as part of the consideration in the acquisition (in Shares)                         592,500                                                
Shares issued as conversion of iDoc debt as part of the consideration in the acquisition                         $ 59 1,184,941 1,185,000                                            
Preferred shares issued to settle debt as part of the consideration in the acquisition (in Shares) 300 1,268 220                                                                    
Preferred shares issued to settle debt as part of the consideration in the acquisition                           $ 300,000 $ 300,000 $ 1,268,000 $ 1,268,000                       220,000               220,000
Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction (in Shares)     4,370                                                                    
Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction     $ 1                                                   4,369,999               4,370,000
Escrow shares released from stock payable (in Shares)                                             239,424                            
Escrow shares released from stock payable                                             $ 24           127,686               $ 127,710
Shares issued in debt settlement or conversion (in Shares)       300,000 114,000                         12,846 60,764 469,606                                  
Shares issued in debt settlement or conversion       $ 30 $ 12 $ 599,970 $ 227,988 $ 600,000 $ 228,000                 $ 1 $ 6 $ 47       $ 155,564 $ 159,875 $ 1,177,436           $ 155,565 $ 159,881 $ 1,177,483      
Reverse recapitalization (in Shares)                                   3,603,966                                      
Reverse recapitalization                                   $ 360           $ (17,957,293)               $ (17,956,933)          
Shares issued as part of stock grants to vendors (in Shares)                                     227,500                                   2,500
Shares issued as part of stock grants to vendors                                     $ 23           $ 625,727               $ 625,750        
Shares issued upon conversion (in Shares)                                         50,000 380,000                         380,000 50,000  
Shares issued upon conversion                                         $ 5 $ 38         $ 79,495 $ 759,962             $ 79,500 $ 760,000  
Shares issued upon conversion of Working Capital Funds Advances (in Shares)                                         202,500                                
Shares issued upon conversion of Working Capital Funds Advances                                         $ 20           $ 404,980               $ 405,000    
Stock-based compensation                                                         826,916               $ 826,916
Net loss                                                           (57,702,015)             (57,702,015)
Ending balance (in Shares) at Dec. 31, 2024     6,158                                       16,297,190                            
Ending balance at Dec. 31, 2024     $ 1                                       $ 1,630           67,683,754 (67,703,873)             (18,488)
Warrants and commitment shares issued in connection with the September 2024 Note (in Shares)                                             100,000                            
Warrants and commitment shares issued in connection with the September 2024 Note                                             $ 10           (10)                
Shares issued upon conversion (in Shares)     (4,370)                                       2,185,000                            
Shares issued upon conversion                                             $ 219           (219)                
Proceeds from pre-funded warrants, net of issuance cost                                                         5,519,085               5,519,085
Shares issued during the year                                             $ 1,380           13,538,484               13,539,864
Shares issued during the year (in Shares)                                             13,807,560                            
Stock-based compensation                                             $ 90           1,134,667               1,134,757
Stock-based compensation (in Shares)                                             903,390                            
Payment to shareholder                                                         (10,000)               (10,000)
Net loss                                                           (14,712,850)             (14,712,850)
Ending balance (in Shares) at Dec. 31, 2025     1,788                                       33,193,140                     25,000      
Ending balance at Dec. 31, 2025     $ 1                                       $ 3,319           $ 87,865,771 $ (82,416,723)             $ 5,452,368